1.0Zomedicahttps://zomedica.comChris MacLeodrich600338<blockquote class="wp-embedded-content" data-secret="W2bandQJpm"><a href="https://zomedica.com/about-zomedica/chris-macleod/">Chris MacLeod</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://zomedica.com/about-zomedica/chris-macleod/embed/#?secret=W2bandQJpm" width="600" height="338" title="“Chris MacLeod” — Zomedica" data-secret="W2bandQJpm" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
Chris MacLeod is a founding partner of Cambridge LLP, a Canadian law firm. Outside his work at Cambridge, Mr. MacLeod is the National Chair of the Canadian Cystic Fibrosis Treatment Society (CCFTS). The Society’s purpose is to advocate across sectors (government, charitable, insurance, and pharma) for access to innovative life-sustaining medication.https://zomedica.com//wp-content/uploads/2023/08/Mask-Group-47@2x-16-1024x1024.png